Hepion (HEPA) director awarded 299K stock options
Rhea-AI Filing Summary
Hepion Pharmaceuticals, Inc. (HEPA) reported that director Danina Fisher received a grant of stock options to acquire 299,000 shares of common stock. The options have an exercise price of $0.08 per share, become exercisable on August 19, 2027, and expire on August 19, 2036. Following this grant, Fisher holds 299,000 derivative securities directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Fisher Danina
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Options | 299,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Options — 299,000 shares (Direct)
Key Figures
Stock options granted: 299,000 options
Exercise price: $0.08 per share
Underlying shares: 299,000 shares
+3 more
6 metrics
Stock options granted
299,000 options
Grant of stock options to director Danina Fisher on August 19, 2026
Exercise price
$0.08 per share
Conversion or exercise price for the granted stock options
Underlying shares
299,000 shares
Common stock underlying the granted stock options
Exercise date
August 19, 2027
Date on which the stock options become exercisable
Expiration date
August 19, 2036
Expiration of the stock options held by Danina Fisher
Holdings after transaction
299,000 derivative securities
Total derivative securities owned directly by Danina Fisher after the grant
Key Terms
Stock Options, exercise price, expiration date, underlying security
4 terms
Stock Options financial
"security_title: "Stock Options""
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
exercise price financial
"conversion_or_exercise_price: "0.0800""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: "2036-08-19""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
underlying security financial
"underlying_security_title: "Common Stock""
FAQ
What did HEPA director Danina Fisher report on this Form 4?
Danina Fisher reported a grant of stock options relating to 299,000 shares of Hepion Pharmaceuticals, Inc. common stock. The options were acquired as a grant or award and are held directly.
What is the exercise price of Danina Fisher’s HEPA stock options?
The stock options granted to Danina Fisher have an exercise price of $0.08 per share. This is the price per share at which the options allow her to acquire Hepion Pharmaceuticals, Inc. common stock once exercisable.
When do Danina Fisher’s HEPA stock options vest and expire?
The options become exercisable on August 19, 2027 and have an expiration date of August 19, 2036. After the expiration date, the options can no longer be exercised for Hepion Pharmaceuticals, Inc. shares.
Is this HEPA Form 4 transaction a buy or sell of common stock?
The Form 4 reports an acquisition of derivative securities through a grant of stock options. It does not report a market purchase or sale of Hepion Pharmaceuticals, Inc. common stock.
AI-generated analysis. How Rhea-AI works. Not financial advice.
